Rare Bone Diseases You Should Never Miss

Friday, May 8, 2020

4:15 PM – 5:15 PM

Participants should be aware of the following financial/non-financial relationships:
E. Michael M. Lewiecki, MD, FACE: Alexion : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing); Amgen : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Radius : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing); Ultragenyx : Consulting Fees (e.g., advisory boards) (Status: Ongoing)
Azeez Farooki, MD: Disclosure information not submitted.

Learning Objectives:

Recognize potentially treatable rare bone diseases
Identify strategies for evaluating rare bone diseases
Describe new and emerging treatments for these diseases

Speaker(s)

E. Michael M. Lewiecki, MD, FACE

Director
NEW MEXICO CLINICAL RESEARCH & OSTEOPOROSIS CENTER

Disclosure: Alexion : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing); Amgen : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Radius : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing); Ultragenyx : Consulting Fees (e.g., advisory boards) (Status: Ongoing)

Moderator(s)

Azeez Farooki, MD

Associate Attending Physician
Memorial Sloan Kettering Cancer Center

Disclosure: Disclosure information not submitted.